Dong Shuilin, Chen Lin, Chen Yifa, Chen Xiaoping
Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore). 2017 Mar;96(13):e6305. doi: 10.1097/MD.0000000000006305.
Primary hepatic mucosa-associated lymphoid tissue (MALT) lymphoma is an extremely rare disease. To the best of our knowledge, only 67 cases had been reported in 39 English literatures to date. The aim of this study was to add a new case of this disease to the literature and to review the current literature.
A 50-year-old man was incidentally identified with a solitary mass of 5 cm in diameter in the left lobe of the liver.
Based on the results of imaging studies, intrahepatic cholangiocellular carcinoma was suspected, and then surgery was performed. Microscopic findings showed that the tumor was a hepatic MALT lymphoma, and immunohistochemical analysis revealed that the lymphoma cells were CD20+, CD79a+, BCL-2+, CD3-, and CD5-.
The patient received rituximab after surgery.
He was free of disease for 13 months at the time of this report.
Since previously published case reports and our case described nonspecific clinical features of this rare disease, it was usually misdiagnosed before histological confirmation and surgery resection may be a good choice for both diagnosis and local therapy.
原发性肝黏膜相关淋巴组织(MALT)淋巴瘤是一种极其罕见的疾病。据我们所知,迄今为止39篇英文文献中仅报道了67例。本研究的目的是为该疾病文献增添1例新病例并回顾当前文献。
一名50岁男性偶然发现肝脏左叶有一个直径5厘米的孤立肿块。
基于影像学检查结果,怀疑为肝内胆管细胞癌,随后进行了手术。显微镜检查结果显示肿瘤为肝MALT淋巴瘤,免疫组化分析显示淋巴瘤细胞CD20+、CD79a+、BCL-2+、CD3-和CD5-。
患者术后接受了利妥昔单抗治疗。
在本报告时,他已无病生存13个月。
由于先前发表的病例报告以及我们的病例均描述了这种罕见疾病的非特异性临床特征,因此在组织学确诊之前通常会被误诊,手术切除可能是诊断和局部治疗的良好选择。